MSKCCMemorial Sloan-Kettering Cancer Center
Copyright 1988-2018, All rights reserved.
References in periodicals archive ?
Furthermore, there is concern over patients included in this study as nearly half the cohort (44%) in the trial were MSKCC poor-risk.
A subsequent phase I/II study at Memorial Sloan Kettering Cancer Center (MSKCC) evaluated the addition of paclitaxel to ifosfamide plus cisplatin (TIP) as initial salvage treatment of 46 patients [14].
Therefore, we investigated the prognostic value of systemic inflammatory markers as well as AST/ALT-related parameters and evaluated those that may be useful in improving survival stratification offered by the current Heng and MSKCC risk models in patients with mRCC treated with targeted therapy.
Patients should also be reminded to leave all valuables at home (MSKCC, 2017b).
Adjuvant therapy after resection of colorectal liver metastases: The predictive value of the MSKCC clinical risk score in the era of modern chemotherapy.
At Memorial Sloan Kettering Cancer Center (MSKCC), [1] the clinical laboratory makes approximately 30 000 critical value calls a year with only 9 analytes accounting for nearly 75% of these calls.
Natalie Gangai is the Project Coordinator on the Geriatric Workforce Enhancement Program at Memorial Sloan Kettering Cancer Center (MSKCC).
In designing CD19 for Leukemia, three (3) different CART therapies were compared from Memorial Sloan Kettering Cancer Center (MSKCC), the National Cancer Institute (NCI), and University of Pennsylvania, (UPenn) [5] (Davila et al.
The Memorial Sloan Kettering Cancer Center (MSKCC) [4] and Heng [5] risk criteria form the bases of prognostic classifications.
Prior to Rogosin, Maryanne served as executive director of The Society of Memorial Sloan-Kettering Cancer Center (MSKCC) from 2007 to 2010.
Taking a closer look at three of these groups, the American Society of Clinical Oncology (ASCO), Memorial Sloan Kettering Cancer Center (MSKCC), and the National Comprehensive Cancer Network (NCCN) will help to illustrate the current discussion around value in oncology.
A survey was administered to inpatient oncology staff at Memorial Sloan Kettering Cancer Center (MSKCC; N = 30), asking them to rate the degree of challenge associated with 10 common family situations that arise in an inpatient setting, as well as interest in training for each.